04.05.2018 12:50:44
|
IDEXX Labs Boosts 2018 EPS Outlook, But Backs Revenue View - Quick Facts
(RTTNews) - IDEXX Laboratories, Inc. (IDXX) on Friday raised its earnings outlook for the full-year 2018 by $0.02 to a range of $4.06 to $4.20 per share, as operational upsides are offset by impacts from updated foreign exchange rate outlook.
However, the company continues to expect 2018 revenue guidance in the range of $2.205 billion to $2.245 billion, reflecting reported growth of 12 to 14 percent, but raised 2018 organic revenue growth guidance by 1 percent to 10.5 to 12.5 percent, which is offset by change in foreign exchange rate outlook.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.12 per share on revenue growth of 12.9 percent to $2.22 billion for the year. Analysts' estimates typically exclude special items.
For 2018, the company also projects capital spending of about $140 million.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 397,90 | 0,76% |